These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5347398)

  • 21. Review analysis of medullary carcinoma thyroid--15-year Indian experience.
    Dorairajan N; Saravanakumar P; Karthikeyan S; Siddharth D; Kanna S
    J Indian Med Assoc; 2005 Aug; 103(8):415-7, 427. PubMed ID: 16363195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal intradermal histamine reaction and elevated serum calcitonin in the syndrome of: medullary carcinoma of the thyroid gland, pheochromocytoma, and multiple mucosal neuromas. A survey and a case in a child with symptoms from early childhood.
    Flensborg EW; Schiotz PO
    Dan Med Bull; 1974 Mar; 21(1):20-6. PubMed ID: 4829109
    [No Abstract]   [Full Text] [Related]  

  • 23. [Sipple syndrome (bilateral phaeochromocytoma medullary C-cell carcinoma of the thyroid gland) with exceptionally prolonged clinical course].
    Kovarik J; Silberbauer K; Woloszczuk W; Krisch K; Geyer G
    Wien Klin Wochenschr; 1982 Jun; 94(13):340-5. PubMed ID: 6127842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review analysis of medullary carcinoma of the thyroid: a 15-year Indian experience.
    Dorairajan N; Siddharth D; Kanna S
    Int Surg; 2006; 91(3):162-7. PubMed ID: 16845858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
    Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin.
    Roos BA; Huber MB; Birnbaum RS; Aron DC; Lindall AW; Lips K; Baylin SB
    J Clin Endocrinol Metab; 1983 Apr; 56(4):802-7. PubMed ID: 6687599
    [No Abstract]   [Full Text] [Related]  

  • 27. Clonal strains of rat medullary thyroid carcinoma cells that produce neurotensin and calcitonin. Functional and morphologic studies.
    Zeytinoglu FN; Gagel RF; DeLellis RA; Wolfe HJ; Tashjian AH; Hammer RA; Leeman SE
    Lab Invest; 1983 Oct; 49(4):453-9. PubMed ID: 6353060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thyroid carcinoma].
    Tamaki H
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):561-5. PubMed ID: 15853229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
    Skinner MA; Wells SA
    Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Medullary cancer of the thyroid and hyperthyrocalcitonin syndrome].
    Milhaud G; Coutris G; Tubiana M
    Presse Med (1893); 1969 Dec; 77(56):2129-32. PubMed ID: 5374252
    [No Abstract]   [Full Text] [Related]  

  • 31. Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma.
    Deftos LJ; Goodman AD; Engelman K; Potts JT
    Metabolism; 1971 Apr; 20(4):428-31. PubMed ID: 4994451
    [No Abstract]   [Full Text] [Related]  

  • 32. Sporadic medullary thyroid carcinoma associated with toxic multinodular goitre.
    Small PK; Smith D
    J R Coll Surg Edinb; 1997 Jun; 42(3):199-200. PubMed ID: 9195818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medullary carcinoma of the thyroid: a clinical contribution].
    Angeli G; Brazzarola P; Bottura D; Bonomo S; Castellini C; Moser A; Vicenzi L; Mazzola F; Rizzo S; Betresini B; Ballarin A; Rosa G
    Chir Ital; 2002; 54(1):25-9. PubMed ID: 11942005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [On a typical case of thyroid medullary carcinoma with demonstrated calcitonin hypersecretion].
    Gilbert-Dreyfus ; Raymond JP; Chomette G; Sebaoun J
    Rev Fr Endocrinol Clin; 1969; 10(3):205-19. PubMed ID: 5821207
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined positron emission tomography/computed tomography imaging of recurrent thyroid cancer.
    Zimmer LA; McCook B; Meltzer C; Fukui M; Bascom D; Snyderman C; Townsend DW; Johnson JT
    Otolaryngol Head Neck Surg; 2003 Feb; 128(2):178-84. PubMed ID: 12601311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Present status of calcitonin research with special attention to conditions in man].
    Sorensen OH; Hindberg I
    Ugeskr Laeger; 1970 Feb; 132(9):426-9. PubMed ID: 4914424
    [No Abstract]   [Full Text] [Related]  

  • 37. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
    Łacka K; Michałek K; Majewski P
    Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic applications of calcitonin immunoassay.
    Deftos LJ; Bronzert D; Parthemore JG
    Ann Clin Lab Sci; 1974; 4(6):484-6. PubMed ID: 4429342
    [No Abstract]   [Full Text] [Related]  

  • 39. [Calcitonin and thyrocalcitonin].
    Ogata E; Suzuki H; Yoshitoshi Y
    Saishin Igaku; 1968 Dec; 23(12):2572-8. PubMed ID: 4889819
    [No Abstract]   [Full Text] [Related]  

  • 40. Identification and characterization of calcitonin forms in plasma and urine of normal subjects and medullary carcinoma patients.
    Tobler PH; Tschopp FA; Dambacher MA; Born W; Fischer JA
    J Clin Endocrinol Metab; 1983 Oct; 57(4):749-54. PubMed ID: 6885964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.